Atlas Private Wealth Management Anavex Life Sciences Corp. Transaction History

Atlas Private Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$10.16 - $28.86 $17,739 - $50,389	-1,746 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$5.17 - $16.13 $982 - $3,064	-190 Reduced 9.81%	1,746 $26,000
Q1 2020 May 12, 2020	BUY	$2.38 - $5.81 $1,190 - $2,905	500 Added 34.82%	1,936 $6,000
Q4 2019 Feb 11, 2020	BUY	$2.31 - $3.14 $3,317 - $4,509	1,436 New	1,436 $4,000

163

27.5M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Atlas Private Wealth Management with notifications on news.